Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Derivative Liability Measured at Fair Value

The table below reflects the activity of derivative liability measured at fair value for the years ended December 31, 2024 and 2023:

	Significant Unobservable Inputs (Level 3)
Balance of derivative liability as of January 1, 2023	$	-
Initial fair value of derivative liability attributable to warrants issuance with May, July, and October 2023 fund raises		213,170
Gain from change in the fair value of derivative liability		(188,374	)
Balance of derivative liability as of December 31, 2023		24,796
Initial fair value of derivative liability attributable to warrants issuance with March and June 2024 fund raises		479,468
Reclassification of additional paid-in capital upon conversion		(2,354	)
Gain from change in the fair value of derivative liability		(374,365	)
Balance of derivative liability as of December 31, 2024	$	127,545

Schedule of Cash Balances by Geographic Area

At December 31, 2024 and 2023, the Company’s cash balances by geographic area were as follows:

Country:	December 31, 2024				December 31, 2023
United States	$	2,844,522	99.6	%	$	280,197	98.2	%
China		11,787	0.4	%		5,203	1.8	%
Total cash	$	2,856,309	100.0	%	$	285,400	100.0	%

Schedule of Securities that were Excluded from the Diluted Per Share

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:

	Years Ended December 31,
	2024		2023
Options to purchase common stock		52,479		56,880
Warrants to purchase common stock		182,996		43,035
Series A convertible preferred stock (*)		60,000		60,000
Series B convertible preferred stock (**)		194,004		194,004
Series C convertible preferred stock (***)		1,452,282		-
Convertible notes (****)		227,269		60,740
Potentially dilutive securities		2,169,030		414,659

(*) Assumed the Series A convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $150.00 per share.

(**) Assumed the Series B convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $56.70 per share.

(***) Assumed the Series C convertible preferred stock was converted into shares of common stock of the Company at a conversion price of $2.41 per share.

(****) Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $11.25 per share for the year ended December 31, 2024. Assumed the convertible notes were converted into shares of common stock of the Company at a conversion price of $67.50 and $22.50 per share for the year ended December 31, 2023.